Emerging pharmacological therapies for ARDS: COVID-19 and beyond

ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory failure. Despite considerable advances in our knowledge regarding the pathophysiology of ARDS, insights into the biologic mechanisms of lung injury and repair, and advances in supportive care, particularly ven...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intensive Care Med
Main Authors: Horie, Shahd, McNicholas, Bairbre, Rezoagli, Emanuele, Pham, Tài, Curley, Ger, McAuley, Danny, O’Kane, Cecilia, Nichol, Alistair, dos Santos, Claudia, Rocco, Patricia R. M., Bellani, Giacomo, Laffey, John G.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Narrative Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352097/
https://ncbi.nlm.nih.gov/pubmed/32654006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00134-020-06141-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados